Benchmark Reaffirms “Buy” Rating for Medicine Man Technologies (OTC:SHWZ)

Benchmark reaffirmed their buy rating on shares of Medicine Man Technologies (OTC:SHWZ) in a research note issued to investors on Wednesday morning, Benzinga reports. They currently have a $2.50 target price on the stock.

Medicine Man Technologies Stock Performance

Shares of SHWZ opened at $0.18 on Wednesday. The stock’s 50-day moving average is $0.28. Medicine Man Technologies has a 12 month low of $0.01 and a 12 month high of $1.55.

Medicine Man Technologies Company Profile

Medicine Man Technologies, Inc, doing business as Schwazze, operates as a cannabis company. It operates through three segments: Retail, Wholesale, and Other. The company offers cannabis products that include loose flower, concentrates, edibles, pre-rolls, topicals, and other associated cannabis products; and vape cartridges and syringes.